Correlation Between Elanco Animal and ArriVent BioPharma,
Can any of the company-specific risk be diversified away by investing in both Elanco Animal and ArriVent BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elanco Animal and ArriVent BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elanco Animal Health and ArriVent BioPharma, Common, you can compare the effects of market volatilities on Elanco Animal and ArriVent BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elanco Animal with a short position of ArriVent BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elanco Animal and ArriVent BioPharma,.
Diversification Opportunities for Elanco Animal and ArriVent BioPharma,
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Elanco and ArriVent is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Elanco Animal Health and ArriVent BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ArriVent BioPharma, and Elanco Animal is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elanco Animal Health are associated (or correlated) with ArriVent BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ArriVent BioPharma, has no effect on the direction of Elanco Animal i.e., Elanco Animal and ArriVent BioPharma, go up and down completely randomly.
Pair Corralation between Elanco Animal and ArriVent BioPharma,
Given the investment horizon of 90 days Elanco Animal is expected to generate 2.17 times less return on investment than ArriVent BioPharma,. But when comparing it to its historical volatility, Elanco Animal Health is 1.17 times less risky than ArriVent BioPharma,. It trades about 0.04 of its potential returns per unit of risk. ArriVent BioPharma, Common is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 1,800 in ArriVent BioPharma, Common on August 31, 2024 and sell it today you would earn a total of 1,111 from holding ArriVent BioPharma, Common or generate 61.72% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 54.57% |
Values | Daily Returns |
Elanco Animal Health vs. ArriVent BioPharma, Common
Performance |
Timeline |
Elanco Animal Health |
ArriVent BioPharma, |
Elanco Animal and ArriVent BioPharma, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Elanco Animal and ArriVent BioPharma,
The main advantage of trading using opposite Elanco Animal and ArriVent BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elanco Animal position performs unexpectedly, ArriVent BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ArriVent BioPharma, will offset losses from the drop in ArriVent BioPharma,'s long position.Elanco Animal vs. Bausch Health Companies | Elanco Animal vs. Haleon plc | Elanco Animal vs. Intracellular Th |
ArriVent BioPharma, vs. WiMi Hologram Cloud | ArriVent BioPharma, vs. Anterix | ArriVent BioPharma, vs. NETGEAR | ArriVent BioPharma, vs. The Mosaic |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Transaction History View history of all your transactions and understand their impact on performance | |
Stocks Directory Find actively traded stocks across global markets |